Breakthrough in HIV Cure Research: Cancer Drug Shows Promise in Eliminating Dormant Virus
Stanford, California – In a groundbreaking development, researchers at Stanford University have discovered that a cancer drug already approved by the U.S. Food and Drug Administration (FDA) could hold the key to curing HIV, a virus that has long eluded a definitive cure. The study, published in the journal Science Advances, reveals that a compound called EBC-46 can reactivate dormant HIV-infected…